# XBP

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xbp

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Series A (Dec 29, 2025)
- Investors on record: 3

## About

Founded in 2018 and based in Shanghai, China, Shanghai Xinguang Bio-pharmaceutical Co., Ltd., trading as XBP is a medical device manufacturing company that focuses on the production and sales of home hemodialysis equipment. It acquired more than 7 international PCT patents. The company settled in the Johnson & Johnson Laboratories in 2019. In December 2025, XBP raised Series A1 funding.
XBP mainly engages in the research, development, production, and sales of hemodialysis devices. Its main product is portable dialysis platforms. The portable dialysis platforms adopt dialysate regeneration technology and pneumatic diaphragm pump technology, which can be carried and relocated. It can provide several treatments such as hemodialysis, peritoneal dialysis, and CRRT. The second-generation engineering prototype of portable dialysis platforms has completed the animal testing phase. Products can be used in the treatment of uremia.
The company’s revenue is generated by sales of biopharmaceutical products and related services to hospitals and healthcare institutions.

## Funding rounds

- Series A, Dec 29, 2025 — Richen Capital
- Angel, Dec 2, 2021 — Empower Investment, Shanghai Joyin Corporate Management

## Investors

- Empower Investment (https://capitalatlas.ai/funds/empower-investment) — Angel
- Shanghai Joyin Corporate Management — Angel
- Richen Capital (https://capitalatlas.ai/funds/richen-capital) — Series A